On October 3, 2018, the US Senate passed H.R. 6 by a vote of 98-1 (after the House of Representatives passed the legislation last week by a vote of 393-8) that incorporates approximately 70 individual bills and multifaceted programs to address the opioid problem. One of the provisions would require advance data on all international mail by 2020 to assist US Customs and Border Protection (CBP) and the US Postal Service interdict small fentanyl and carfentanil shipments, that are shipped through international mail channels, particularly from China. The bill is now headed to the White House for President Donald Trump’s signature.
You are here: / / US – Opioids bill heads to the President for signature